Institutes
Refine
Year of publication
- 2022 (365) (remove)
Document Type
- Article (310)
- Preprint (22)
- Conference Proceeding (19)
- Doctoral Thesis (14)
Language
- English (365) (remove)
Has Fulltext
- yes (365)
Is part of the Bibliography
- no (365)
Keywords
- inflammation (8)
- COVID-19 (7)
- Inflammation (6)
- bladder cancer (5)
- data science (5)
- glioblastoma (5)
- prostate cancer (5)
- ADHD (4)
- Cancer (4)
- SARS-CoV-2 (4)
- Surgery (4)
- cancer (4)
- glioma (4)
- hepatocellular carcinoma (4)
- Biomarker (3)
- Lung failure (3)
- Radiotherapy (3)
- artificial intelligence (3)
- digital medicine (3)
- immunotherapy (3)
- machine learning (3)
- machine-learning (3)
- periodontitis (3)
- polypharmacy (3)
- radical prostatectomy (3)
- stroke (3)
- ACLF (2)
- Accidental reaction (2)
- Allergen avoidance (2)
- Anti-IgE (2)
- Attention-deficit/hyperactivity disorder (2)
- Biomedical informatics (2)
- COVID-19 surveillance (2)
- Cochlear implant (2)
- Data science (2)
- Depression (2)
- Elderly (2)
- Emotion regulation (2)
- EphB4 (2)
- Epicutaneous immunotherapy (2)
- Epigenetics (2)
- Geriatric patients (2)
- Germany (2)
- Immunology (2)
- MRI (2)
- Magnetic resonance imaging (2)
- Medical research (2)
- NADPH oxidase (2)
- NS5A (2)
- NSCLC (2)
- Omicron (2)
- Oncology (2)
- Oral immunotherapy (2)
- Penile carcinomas (2)
- Prostate cancer (2)
- RNAseq (2)
- Rectal cancer (2)
- SARS-CoV-2 monitoring (2)
- SPM (2)
- Sex (2)
- T-cell (2)
- TAVI (2)
- TIPS (2)
- Tight junctions (2)
- Translational research (2)
- Uteroglobin (2)
- antiseizure medication (2)
- autophagy (2)
- biliary stricture (2)
- brain metastases (2)
- brain metastasis (2)
- cartilage (2)
- chemotherapy (2)
- child (2)
- cognition (2)
- coronavirus (2)
- depression (2)
- diagnosis (2)
- elderly (2)
- ephrinB2 (2)
- epilepsy (2)
- functional outcome (2)
- general practice (2)
- glycolysis (2)
- growth (2)
- hyperglycemia (2)
- hypoxia (2)
- immune checkpoint inhibitors (2)
- immunity (2)
- immunohistochemistry (2)
- integrins (2)
- invasion (2)
- leptin (2)
- lipoxygenase (2)
- long non-coding RNA (2)
- macrophage (2)
- microRNA (2)
- microglia (2)
- motility (2)
- multimorbidity (2)
- neurodegeneration (2)
- neuropathic pain (2)
- nivolumab (2)
- nociception (2)
- osteoarthritis (2)
- outcomes (2)
- pain (2)
- pandemic (2)
- patients (2)
- pediatric surgery (2)
- process evaluation (2)
- proteomics (2)
- quality of life (2)
- radical cystectomy (2)
- resolution of inflammation (2)
- scaffold (2)
- sphingolipids (2)
- stereotactic radiosurgery (2)
- temozolomide (2)
- transcription factor (2)
- traumatic brain injury (2)
- tumor microenvironment (2)
- vaccination (2)
- 177Lu-PSMA-617 (1)
- 223Radium-dichloride (1)
- 3 mm RAS instruments (1)
- 3 mm instruments (1)
- 3-hydroxyisovaleryl carnitine (1)
- 3D culture (1)
- 3D laparoscopy (1)
- 3D-models (1)
- 3D-printing (1)
- A498 cells (1)
- ABC transporter (1)
- ACKR (1)
- ADHS (1)
- AKT-mTOR pathway (1)
- AML (1)
- ARDS (1)
- Ablation Techniques (1)
- Acinetobacter baumannii (1)
- Active middle ear implants (1)
- Activities of daily living (1)
- Acute (1)
- Acute decompensation (1)
- Acute kidney injury (1)
- Acute myeloid leukaemia (1)
- Acute-on-chronic liver failure (1)
- Affect (1)
- Aggression (1)
- Aging (1)
- Akt-mTOR pathway (1)
- Akt-mTOR signaling (1)
- Ambulatory Assessment (1)
- Anaemia (1)
- Anakinra (1)
- Angiogenesis (1)
- Angiography (1)
- Animal models (1)
- Antibiotics (1)
- Antibodies (1)
- Antigen test (1)
- Aortic stenosis (1)
- Aperiodic (1)
- Apoptosis (1)
- Arteria ophthalmica (1)
- Aspergillus (1)
- Ataxia (1)
- Atrial fibrillation classification (1)
- Attentional bias (1)
- Auditory system (1)
- Autoimmunity (1)
- Autophagy (1)
- Autopsy (1)
- B.1.1.529 (1)
- BA.4 (1)
- BA.5 (1)
- BET proteins (1)
- BH3 mimetics (1)
- BMNC (1)
- BMP4 (1)
- BNT162b2 (1)
- Bacillus subtilis (1)
- Bacteraemia (1)
- Bacteria (1)
- Balance (1)
- Bartonella adhesin A (1)
- Behavioral tests (1)
- Bentall operation (1)
- Biceps brachii (1)
- Bilateral sagittal split osteotomy (1)
- Biological sciences (1)
- Bipolar disorder (1)
- Blindness (1)
- Blood loss (1)
- Blood pressure (1)
- Blood sample handling (1)
- Bloodstream infections (1)
- Body modification (1)
- Bone conduction devices (1)
- Bone dust (1)
- Bone marrow aspiration (1)
- Brachytherapy (1)
- Brodalumab (1)
- C-reactive protein (1)
- CAR (1)
- CBC (1)
- CD4+ T cells (1)
- CD40 (1)
- CDK-cyclin axis (1)
- CHRDL1 (1)
- CK2α (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- CLOCC (1)
- CNS tumor (1)
- COMP (1)
- COVID-19 epitope signatures (1)
- CQL (1)
- CRP (1)
- CRT (1)
- CT (1)
- CTGF (1)
- CXCL13 (1)
- CaMPARI (1)
- Calliphoridae (1)
- Cardiac remodeling (1)
- Cardiovascular diseases (1)
- Case report (1)
- Catheters (1)
- Cell Biology (1)
- Cell death (1)
- Cell death and immune response (1)
- Cellular network formation (1)
- Central Europe (1)
- Cerebellum (1)
- Cerebral oxygen saturation (1)
- ChAdOx1-S (1)
- Chemoradiotherapy (1)
- Chemotherapy (1)
- Chronic lymphocytic leukemia (1)
- Circulating MiRNA (1)
- Cirrhosis (1)
- Classification (1)
- Click chemistry (1)
- Clinical Trials and Observations (1)
- Clinical management (1)
- Clinical phenotype (1)
- Clinical practice guidelines (1)
- Clinical trials (1)
- Cognition (1)
- Cognitive (1)
- Colloids (1)
- Colony stimulating factor 1 receptor (1)
- Comorbidities (1)
- Comorbidity (1)
- Comparative analysis (1)
- Complete response (1)
- Completed suicide (1)
- Complex elbow fractures (1)
- Comprehensive complication index (1)
- Computer software (1)
- Concurrent CNS diseases (1)
- Congenital (1)
- Connective tissue (1)
- Consensus statement (1)
- Conventional and unconventional ubiquitination (1)
- Convolutional Neural Networks (1)
- Coronavirus (1)
- Coronaviruses (1)
- Culex pipiens biotypes pipiens/molestus (1)
- CysLTR1 (1)
- D-amino acid oxidase (1)
- DAA (1)
- DNA methylation (1)
- DNA mismatch repair (1)
- DNA-based identification (1)
- DVI (1)
- DWI (1)
- Data preprocessing (1)
- Data structure detection (1)
- Deep brain stimulation (1)
- Deep neural network (1)
- Degradation (1)
- Dental students (1)
- Detection workflow (1)
- Dexterity (1)
- Diagnostic imaging (1)
- Diagnostic tests (1)
- Diet (1)
- Donor screening (1)
- Dot-probe task (1)
- Downgrading (1)
- Dynamic MRI (1)
- EEG (1)
- EGFR (1)
- ER stress (1)
- Elderly trauma patient (1)
- Emotional intelligence (1)
- Empathy (1)
- Endocannabinoids (1)
- Endogenous retroviruses (ERV) (1)
- Endoluminal (1)
- Endorectal (1)
- Endothelial (1)
- Endothelial-to-mesenchymal transition (1)
- Energy-efficiency (1)
- Environmental impacts (1)
- Epidemiology (1)
- Epilepsy (1)
- Erythrophagocytosis (1)
- Europe (1)
- Euthymic phase (1)
- Explicit (1)
- Extracorporeal devices (1)
- FDG-PET/CT (1)
- FFLU (1)
- FHIR (1)
- FHIR Search (1)
- FPR (1)
- Face masks (1)
- Fall (1)
- Famines (1)
- Fast Healthcare Interoperability Resources (1)
- Feasibility (1)
- Fetal heart (1)
- Fibroblast (1)
- Filgrastim (1)
- Filler (1)
- Follicular lymphoma (1)
- Follow-ups (1)
- Fondaparinux (1)
- Fracture models (1)
- Frameshift (1)
- Fruit fly (1)
- Functional electrical stimulation (1)
- Functional outcomes (1)
- Funktionelle Bildgebung (1)
- G3BP1 (1)
- GDF11 (1)
- GEMs (1)
- GPCR (1)
- GRAND-SLAM (1)
- GSH (1)
- Gene (1)
- Gene expression (1)
- Gene sequencing (1)
- Genetic loci (1)
- Genetic networks (1)
- Genetics (1)
- Genetics research (1)
- Geschlecht (1)
- Glabella (1)
- Gleason Grade group (1)
- Glioblastoma (1)
- Gradient boosting (1)
- Groin pain (1)
- Gut bacteria (1)
- GvL (1)
- HCV (1)
- HEOR (1)
- HES (1)
- HIF (1)
- HIF-1α (1)
- HIF-2α (1)
- HIF-2α, erythropoietin (1)
- HIPPO signalling (1)
- HL7 FHIR (1)
- HNSCC (1)
- HPV infection (1)
- HSCT (1)
- Haemodialysis (1)
- Hardware erosion (1)
- Head neck cancer (1)
- Health policy (1)
- Health sciences (1)
- Healthcare (1)
- Healthy stem cell donors (1)
- Heart defects (1)
- Heart rate (1)
- Hematoma (1)
- Hematopoietic stem cell transplant (1)
- Hemosiderin (1)
- Hepatitis C (1)
- Hepatitis C antibodies (1)
- Hepatitis C antigens (1)
- Hepatotoxicity (1)
- Heterologous prime-boost (1)
- High oblique sagittal osteotomy (1)
- Hip revision (1)
- HoLEP (1)
- Hodgkin lymphoma (1)
- Holmium laser enucleation (1)
- Home Care Services [MeSH] (1)
- Human chorionic villi mesenchymal stromal cells (1)
- Human retroelements (1)
- Human visual cortex (1)
- Hydroxyethyl starch (1)
- Hypertension (1)
- Hypertensive disorders in pregnancy (1)
- IGF-1 (1)
- IL-17 (1)
- Idelalisib (1)
- Identification (1)
- Identifier (1)
- Immunity (1)
- Immunoassay (1)
- Immunogenicity (1)
- Immunotherapy (1)
- Implicit (1)
- Impoverishment (1)
- Impulse generator (1)
- In-TIPS thrombosis (1)
- Incidental prostate cancer (1)
- Induction therapy (1)
- Inequality (1)
- Inguinal hernia (1)
- Inguinal pain (1)
- Inherited arrhythmic syndrome (1)
- Interaction (1)
- Interleukin-1 (1)
- Intermediate-risk (1)
- Intraoperative procedure (1)
- Intravenous iron (1)
- Iron deficiency (1)
- Jaw surgery (1)
- Jurkat (1)
- Kidneys (1)
- Knee joint sound (1)
- Knee osteoarthritis (1)
- Knees (1)
- LAMTOR1 (1)
- LASS (1)
- LC-MS-based lipid mediator analysis (1)
- LCD-Array (1)
- Large vessel occlusion (1)
- Lee-type (1)
- Legionella pneumophila (1)
- Legs (1)
- Ligand post-insertion (1)
- Lipid peroxidation (1)
- Liver (1)
- Liver Fibrosis (1)
- LncRNA (1)
- Local therapy (1)
- Long interspersed nuclear elements (LINE) (1)
- Long-term follow-up (1)
- Long-term results (1)
- Low-molecular-weight heparin (1)
- MAP kinase (1)
- MEN1 (1)
- MGMT (1)
- MGMT promoter (1)
- MLH1 (1)
- MMPs (1)
- MUTARS® RS Cup System (1)
- MUTARS® RS cup system (1)
- Machine learning (1)
- Machine-learning (1)
- Maintenance therapy (1)
- Major depressive disorder (1)
- Malignancy (1)
- Malnutrition (1)
- Masquelet technique (1)
- Mathematical biosciences (1)
- Medical Oncology (1)
- Mental disorder (1)
- Metabolism (1)
- Metastasis (1)
- Methylation (1)
- MiR-29 (1)
- Microbiology, Virology & Host Pathogen Interaction (1)
- Microbiome (1)
- Microenvironment (1)
- Microglia (1)
- Mild hypoxia (1)
- Mini-monovision (1)
- Mitochondria (1)
- Mixed hearing loss (1)
- Model organisms (1)
- Molecular autopsy (1)
- Molecular mimicry (1)
- Monocyte gene expression (1)
- Mood (1)
- Morphology (1)
- Mortality (1)
- Motility (1)
- Mouse (1)
- Mouse models (1)
- Multi-stakeholder approach (1)
- Multi-syndrome classification (1)
- Multiple sclerosis (1)
- Muscle (1)
- Muscle analysis (1)
- Muscle damage (1)
- Muscle pain (1)
- Myeloid Neoplasia (1)
- Myocardial infarction (1)
- Myocarditis (1)
- NASH (1)
- NIS (1)
- NR4A2 (1)
- NR4A3 (1)
- NVBP (1)
- Needs Assessment [MeSH] (1)
- Neurodegenerative syndromes (1)
- Neurodevelopmental disorder (1)
- Neuromuscular exercise (1)
- Neuroscience (1)
- Non-diffractive EDOF-IOL (1)
- Nonoperative management (1)
- Nox (1)
- Nox inhibition (1)
- Nrf2 (1)
- Obesity (1)
- Observational (1)
- Occlusion (1)
- Older patients (1)
- Omicron variant BA.1 (1)
- One-leg stand (1)
- Online education (1)
- Ophthalmoplegia (1)
- Optical phenomena (1)
- Organ preservation (1)
- Orthognathic surgery (1)
- Orthopaedics (1)
- Oscillating saws (1)
- Outcome (1)
- PBBM (1)
- PCR (1)
- PD-L1 (1)
- PDPK1 (1)
- PI3K inhibitor (1)
- PLGA (1)
- PMI (1)
- PPTC7 (1)
- PRG5 (1)
- PSMA (1)
- PacBio SMRT sequencing (1)
- Paediatric cancer (1)
- Palliative Care [MeSH] (1)
- Pandemic (1)
- Papillon-Lefèvre syndrome (1)
- Parkinson’s disease (1)
- Particle load reduction (1)
- Particle size distribution (1)
- Particulate matter (1)
- Patient Outcome Assessment [MeSH] (1)
- Patient Reported Outcome Measures [MeSH] (1)
- Patient care (1)
- Patient safety (1)
- Periodic (1)
- Peripheral blood smears (1)
- Personality inventory (1)
- Phagocytosis (1)
- Physical activity (1)
- Physical and mental health (1)
- Physics (1)
- Placental organoids (1)
- Plasma (1)
- Plasticity (1)
- Polytrauma (1)
- Positron emission tomography (1)
- Post-mortem genetic screening (1)
- Postural control (1)
- Postural sway (1)
- Pre-analytics (1)
- Pre-operative radiotherapy (1)
- Precision medicine (1)
- Preclinical research (1)
- Predictive markers (1)
- Predominant polarity (1)
- Preeclampsia (1)
- Presbyopia (1)
- Primary cilium (1)
- Propensity score matching (1)
- Protein (1)
- Protocol (1)
- Pseudomonas aeruginosa (1)
- Psychiatric traits (1)
- Purdue Pegboard (1)
- Qualitative Research [MeSH] (1)
- Quality of Health Care [MeSH] (1)
- Quality of life (1)
- Quantitative Imaging (1)
- Quarantine (1)
- RAS (1)
- RCC (1)
- RCT (1)
- RESLES (1)
- RNA (1)
- RNA stability (1)
- RNA therapeutics (1)
- RNA turnover (1)
- RNA virus (1)
- Rab7 (1)
- Radical prostatectomy (1)
- Ragulator complex (1)
- Random forest (1)
- Randomized controlled trials (1)
- Reactogenicity (1)
- Real world study (1)
- Refractive lense exchange (1)
- Registry (1)
- Rehabilitation (1)
- Relapse surveillance (1)
- Research data (1)
- Research patterns (1)
- Research validity (1)
- Resilience (1)
- Rhabdomyosarcoma (1)
- Rheumatoid arthritis (1)
- Ribosomal RNA (1)
- Risk assessment (1)
- Rodents (1)
- Routinely Collected Health Data [MeSH] (1)
- S1P (1)
- S1P receptors (1)
- S1P5 (1)
- S1PR5 (1)
- SARS coronavirus (1)
- SARS-CoV-2 testing (1)
- SARS-CoV-2-specific T cells (1)
- SARS-CoV2 (1)
- SF-12 (1)
- SLAM-seq (1)
- SMOC1 (1)
- SOD (1)
- SSTI (1)
- STAT3 (1)
- SUDEP (1)
- Safety culture (1)
- Sanger Sequencing (1)
- Sarcophagidae (1)
- Scalp defect (1)
- Scheduling of radiotherapy (1)
- Schizophrenia (1)
- Screening (1)
- Self-renewal (1)
- Sequelae (1)
- Serology (1)
- Serum (1)
- Siderosis (1)
- Single positive core biopsy (1)
- Skeletal muscles (1)
- Sodium chloride (1)
- Soft tissue sarcoma (1)
- Sphk1 (1)
- Sphk2 (1)
- Sports and exercise medicine (1)
- Statin (1)
- Stoppa approach (1)
- Stroke unit (1)
- Sudden cardiac death (1)
- Sudden death (1)
- Suicide (1)
- Suicide attempt (1)
- Superficial vein thrombosis (1)
- Support vector machine (1)
- Surgical oncology (1)
- Synapse (1)
- Synovial sarcoma (1)
- Systems & Computational Biology (1)
- T helper cell differentiation (1)
- TBI (1)
- TIRADS (1)
- TOR signalling (1)
- TTW nodules (1)
- TUR-P (1)
- Targeted delivery (1)
- Targeted therapies (1)
- Tattoo (1)
- Teaching (1)
- Technical data (1)
- Temozolomide (1)
- Therapy (1)
- Thoracic trauma (1)
- Tissue expander (1)
- Tissue microarray (1)
- Total elbow arthroplasty (1)
- Toxicity (1)
- Training (1)
- Transfusion (1)
- Transitional fractures 3D printing (1)
- Transjugular Intrahepatic Portosystemic Shunt (1)
- Transjugular intrahepatic portosystemic shunt (1)
- Transurethral resection of the prostate (1)
- Trauma (1)
- Trauma centre (1)
- TraumaRegister DGU® (1)
- Traumatic brain injury (1)
- Traumatology (1)
- Travel regulations (1)
- Treatment (1)
- Treatment management (1)
- Treatment response (1)
- Truncating mutation (1)
- Truncus arteriosus (1)
- Tumor microenvironment (1)
- Tumour immunology (1)
- UGCG (1)
- UPR (1)
- USP32 (1)
- Ultrasound (1)
- Undergraduate (1)
- Upgrading (1)
- Urinary continence (1)
- Urinary incontinence (1)
- Urine (1)
- Urological oncology (1)
- V4 (1)
- VUS (1)
- Vaccination (1)
- Valvular cardiomyopathy (1)
- Variant of concern (1)
- Vasculitis (1)
- Venous thrombosis (1)
- Vibroarthrography (1)
- Viral hepatitis (1)
- Viral infection (1)
- Viral oncology (1)
- Virological testing (1)
- Visual-field localizer (1)
- Volume therapy (1)
- Von Hippel–Landau (1)
- Wastewater-based epidemiology (WBE) (1)
- Zebrafish (1)
- Zuckerkandl’s tubercle (1)
- aGVHD (1)
- acarboxyprothrombin (1)
- acetabular fracture (1)
- acute infections (1)
- acute lymphoblastic leukemia (1)
- acute respiratory distress syndrome (1)
- acute stroke (1)
- acute-on-chronic liver failure (1)
- additive manufacturing (1)
- adipose-derived stromal/stem cells (1)
- adjuvant chemotherapy (1)
- adolescents (1)
- age (1)
- aging (1)
- albumin (1)
- alcohol (1)
- algorithm (1)
- aligners (1)
- alpha-fetoprotein (1)
- alphaSynuclein (1)
- alternative splicing (1)
- alveolar ridge augmentation (1)
- amygdalin (1)
- anaplastic large cell lymphoma (1)
- anemia (1)
- anesthesia (1)
- angiogenesis (1)
- animal model (1)
- anorexia nervosa (1)
- anti-EGFR therapy (1)
- anti-bacterial agents (1)
- anti-inflammatory agent (1)
- antiangiogenic therapy (1)
- antiangiogenic therapy resistance (1)
- antioxidant (1)
- antiviral agents (1)
- aortic stenosis (1)
- apex (1)
- arachidonic acid (1)
- articular chondrocytes (1)
- asparaginyl endopepdidase (AEP) (1)
- atezolizumab (1)
- attachment loss (1)
- attention (1)
- atypical EGFR mutations (1)
- autophagy-dependent cell death (1)
- awake surgery (1)
- benchmarking (1)
- beta2-adrenoceptor (1)
- bevacizumab (1)
- biofilm (1)
- bioimaging (1)
- bioinformatics (1)
- biomarker (1)
- biorelevant dissolution (1)
- biotin deficiency (1)
- bone (1)
- bone marrow microenvironment (1)
- bone metastasis (1)
- bone regeneration (1)
- bone tissue engineering (1)
- bowel management (1)
- breast cancer (1)
- breast tumor (1)
- bromodomain and extraterminal (BET) protein (1)
- bronchial epithelium (1)
- bulimia nervosa (1)
- burden of illness (1)
- cabazitaxel (1)
- cabozantinib (1)
- cardiovascular system (1)
- caregivers (1)
- casein kinase 2 (1)
- cataract surgery (1)
- cataract surgery workflow (1)
- cellular heterogeneity (1)
- cellular inflammatory response (1)
- ceramide synthase (1)
- cerebral pseudoprogression (1)
- cerebral vasospasm (CVS) (1)
- cerebrovascular disease (1)
- chemoradiotherapy (1)
- chemorefractory metastatic colorectal cancer (1)
- children (1)
- chimeric antigen receptor (CAR) (1)
- chromaffin cell (1)
- chronic hypoxia (1)
- chronic infections (1)
- clear cell renal cell carcinoma (1)
- clear lens exchange (1)
- climate change genomics (1)
- clinical decision support (1)
- clinical isolates (1)
- clinical outcome (1)
- clinical study (1)
- clinically relevant dissolution specifications (1)
- co-infection (1)
- cognitive impairment (CI) (1)
- colon (1)
- colony formation (1)
- colorectal cancer (1)
- complementary medicine (1)
- complementary/alternative medicine (CAM) (1)
- complication (1)
- computational pathology (1)
- confinement (1)
- congenital duodenal obstruction (1)
- consensus classification (1)
- consensus data set (1)
- constipation (1)
- continuity of care (1)
- copper free strain-promoted azide alkyne cycloaddition (SPAAC) (1)
- corpus callosum (1)
- cortex-based alignment (1)
- cortical impact (1)
- corticospinal tracts (1)
- cost analysis (1)
- cost containment (1)
- cost of illness (1)
- counseling (1)
- counselling (1)
- critical care (1)
- critical size defect (1)
- cryopreservation (1)
- cystic fibrosis (1)
- cytochrome c oxidase I (COI) (1)
- cytokine(s) (1)
- cytosolic free calcium (1)
- data analysis (1)
- data management (1)
- de novo transcription (1)
- decision tree (1)
- deep learning (1)
- delay (1)
- delayed cerebral ischemia (DCI) (1)
- dendritic cell (1)
- dental academic degrees (1)
- dental educationcation (1)
- dental implants (1)
- deproteinized bovine bone matrix (DBBM) (1)
- detection task (1)
- deubiquitinase (DUB) (1)
- diabetes (1)
- diagnostic imaging (1)
- differential expression (1)
- diffusion-weighted magnetic resonance imaging (1)
- digital decision-support (1)
- disease vectors (1)
- distributed analysis (1)
- docetaxel (1)
- doctoral degrees (1)
- dopamine (1)
- double negative (1)
- double-pigtail stents (1)
- dysphagia (1)
- eating disorders (1)
- economic burden (1)
- education (1)
- efficiency (1)
- eicosanoid (1)
- electron transfer chain (1)
- electronic diaries (1)
- enamel matrix derivatives (1)
- encephalopathy (1)
- endoscopic retrograde cholangiography (1)
- endothelial cells (1)
- endovascular recanalization (1)
- endovascular treatment (1)
- ensemble cNN (1)
- environmental tobacco smoke (1)
- epidural (1)
- epoxyeicosatrienoic acid (1)
- erectile dysfunction (1)
- ergonomics (1)
- everyday tasks (1)
- evidence-based guideline (1)
- exosome (1)
- extracellular vesicles (1)
- eye tracking (ET) (1)
- fMRI (1)
- fall (1)
- fat pad resection (1)
- feasibility study (1)
- federated feasibility queries (1)
- fibrin-glue-spray technique (1)
- fibrosis (1)
- flow cytometry (1)
- fluorescence in situ hybridization (FISH) (1)
- focal therapy (1)
- foreign body reaction (1)
- fragment screening (1)
- fragment-size analyses (ACE2; CQ11) (1)
- fungal sinusitis (1)
- gangliosides (1)
- gasotransmitters (1)
- gene expression (1)
- gene signature (1)
- gene therapy (1)
- general practitioners (1)
- genetic variability (1)
- glioblastoma survival (1)
- glioma stem-like cells (1)
- globosides (1)
- glomerulus (1)
- glucose and lipid metabolism (1)
- glucosylceramide (1)
- gravity (1)
- guided bone regeneration (1)
- guided tissue regeneration (1)
- habitat (1)
- haemophilia treatment (1)
- head and neck squamous cell carcinoma (1)
- health behavior (1)
- health care (1)
- health data (1)
- health education (1)
- health services research (1)
- health-related quality of life (1)
- healthcare system (1)
- hematopoietic stem cell transplantation (1)
- hemorrhage (1)
- hemorrhagic transformation (1)
- hepatitis B (1)
- hepatitis B surface antigen (1)
- hepatitis C virus (1)
- hepatitis D (1)
- hidradenitis suppurativa (1)
- hierarchical clustering (1)
- high throughput screening (1)
- high-content screen (1)
- hippocampal sclerosis (1)
- histology (1)
- home training (1)
- hospital length of stay (1)
- host matrix- pathogen interaction (1)
- human MSCs (1)
- human monoclonal antibody (1)
- human research (1)
- human-liver chimeric mouse model (1)
- hybrids (1)
- hydrogen sulfide (H2S) (1)
- hyperactivity (1)
- hypnotics and sedatives (1)
- hypoxia-inducible factor-2α (1)
- immune checkpoint inhibitors (ICI) (1)
- immune monitoring (1)
- immune related adverse events (irAE) (1)
- immune therapy (1)
- immunosenescence (1)
- inborn errors of immunity (1)
- indoor air (1)
- inertial motion capture (1)
- inertial sensors (1)
- infection (1)
- inflammatory bowel disease (1)
- infrapatellar fat pad (1)
- inguinal hernia (1)
- instructional film and video (1)
- insulin sensitivity (1)
- integrative medicine (1)
- interactions (1)
- interferon induction (1)
- interferon sensitivity (1)
- internet (1)
- intracellular multiplication (1)
- intrahepatic cholangiocarcinoma (1)
- intraoral scanning (1)
- invasive fungal infection (1)
- kidney function (1)
- kinematic analysis (1)
- knee osteoarthritis (1)
- lacto/neo-lacto series GSLs (1)
- laparoscopic inguinal hernia repair (1)
- laser-induced thermotherapy (1)
- latent factor mixed model (1)
- legumain (1)
- length of stay (1)
- leukaemia (1)
- leukotriene (1)
- lipids (1)
- lipoxin (1)
- lipoxygenase inhibitor (1)
- liver (1)
- liver fibrosis (1)
- liver transplantation (1)
- local antibiotics (1)
- lockdown (1)
- long-term results (1)
- low-glycaemic meal replacement (1)
- lppr5 (1)
- lung cancer (1)
- lung tumor heterogeneity (1)
- lysophospholipids (1)
- lysosomal-dependent cell death (1)
- lysosome (1)
- mCRPC (1)
- mRNA (1)
- mTOR (1)
- mTORC1 (1)
- macaque (1)
- macrophage polarization (1)
- mappers (1)
- mapping-algorithms (1)
- mechanical accuracy (1)
- mechanical ventilation (1)
- medical informatics (1)
- medication management (1)
- medication review (1)
- melanoma (1)
- membrane remodeling (1)
- membranous urethra (1)
- mesangial cells (1)
- mesenchymal stromal/stem cells (1)
- metabolomics (1)
- metastases (1)
- metastasis (1)
- metastatic prostate cancer (1)
- miR (1)
- microbiology (1)
- microlaparoscopy (1)
- microstimulation (1)
- microwave ablation (1)
- mid-term urinary continence (1)
- mineralization (1)
- minimal invasive (1)
- minimally invasive surgery (1)
- mitochondria (1)
- mixed infection (1)
- model builder software (1)
- modelling (1)
- molecular diagnostic techniques (1)
- molecular subtyping (1)
- molecular typing (1)
- monitoring (1)
- monocytes (1)
- mortality (1)
- multicentre study (1)
- multidetector computed tomography (1)
- multidrug resistance (1)
- multidrug resistance protein 4 (1)
- multiparametric magnetic resonance imaging (1)
- multiple myeloma (1)
- multiple sclerosis (1)
- multiplex immunohistochemistry (1)
- multiplexed immunofluorescence (1)
- multispectral flow cytometry (1)
- musculoskeletal disorders (1)
- neoadjuvant chemoradiotherapy (1)
- neoadjuvant chemotherapy (1)
- neoadjuvant immunochemotherapy (1)
- nephropathy (1)
- nerve-sparing surgery (1)
- neuroblast (1)
- neurocognition (1)
- neurocognitive outcome (1)
- neuroendocrine (1)
- neurological complication (1)
- neurological side effects (1)
- neurooncology (1)
- neuropathy (1)
- neurysmal subarachnoid hemorrhage (aSAH) (1)
- neutralization (1)
- neutropenia (1)
- neutrophil elastase (1)
- newly diagnosed glioblastoma (1)
- nitric oxide (1)
- noise (1)
- non-neutropenic episode (1)
- non-organ confined stage (1)
- non-small-cell lung cancer (1)
- non-surgical periodontal therapy (1)
- nonsense-mediated mRNA decay (1)
- normal liver cells (1)
- novel technologies (1)
- nuclear receptor (1)
- nuclear receptor-related 1 (1)
- obstetric pain (1)
- obstetrics (1)
- oedema (1)
- olfaction (1)
- olfactory testing (1)
- olive mill wastewater (OMWW) (1)
- open (1)
- oral cavity cancer (1)
- oral drug products (1)
- osteoblast (1)
- osteoclasts (1)
- osteogenic differentiation (1)
- outpatient care (1)
- outpatients (1)
- overall survival (1)
- oxidative phosphorylation (1)
- p16 (1)
- pain management (1)
- parabolic flight (1)
- passive smoke (1)
- pathogenicity (1)
- patient centered care (1)
- patient data (1)
- patient-centred care (1)
- patient-reported outcomes (1)
- pediatric robotic surgery (1)
- pembrolizumab (1)
- percutaneous thermal ablation (1)
- peri-implantitis (1)
- periodontal– systemic disease interactions (1)
- peripheral injury (1)
- phantom study (1)
- pharmacophore model (1)
- phase I (1)
- phosphatidylethanolamines (1)
- phospholipid (1)
- phosphorylation (1)
- physical activity (1)
- physical performance (1)
- pimozide (1)
- platinum-based chemotherapy (1)
- plppr5 (1)
- pole concept of goiter growth (1)
- portal vein (1)
- posterior horn (1)
- posteroinferior horn (1)
- postgraduate edu (1)
- postnatal care (1)
- postoperative pain (1)
- postoperative radiochemotherapy (1)
- postoperative radiotherapy (1)
- prediction (1)
- predictive (1)
- predictive biomarker (1)
- predictor (1)
- prenatal diagnostic (1)
- prevention (1)
- preventive health services (1)
- primary care (1)
- primary health care (1)
- print and press (1)
- private brands (1)
- product performance (1)
- professional soccer players (1)
- prognosis (1)
- prognostic (1)
- prone position (1)
- propensity score matching (1)
- prostaglandin (1)
- prostaglandins (1)
- prostate neoplasia (1)
- prostatectomy (1)
- proteasomal processing escape (1)
- proteasome (1)
- protein-rich (1)
- prothrombin induced by vitamin K absence-II (1)
- pulmonary embolism (1)
- pulmonary failure (1)
- pulmonary ventilation (1)
- purification (1)
- qualitative research (1)
- query (1)
- race/ethnicity disparities (1)
- radiation (1)
- radiotherapy (1)
- range expansion (1)
- rat model (1)
- re-exposure (1)
- reactive oxygen species (1)
- real world (1)
- realist synthesis (1)
- rechallenge (1)
- recurrence pattern (1)
- recurrent cholangitis (1)
- refractive lens exchange (1)
- refractive surgery (1)
- reintroduction (1)
- renal fibroblasts (1)
- renal inflammation (1)
- resistant cell lines (1)
- resolvin (1)
- respiratory failure (1)
- respiratory infections (1)
- resveratrol (1)
- rheumatoid arthritis (1)
- rhinovirus (1)
- rifampin (1)
- risk assessment (1)
- risk of malignancy (1)
- robot-guided stereotaxy (1)
- robotic-assisted (1)
- robotically assisted surgery (1)
- robotics (1)
- seasonal adaption (1)
- seizure (1)
- seizures (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- shape (1)
- short-course antibiotic therapy (1)
- siRNA lipid nanoparticles (LNPs) (1)
- single-cell RNA sequencing (1)
- single-cell proteomics (1)
- sleep quality (1)
- smoking behavior (1)
- social recognition (1)
- soft tissue (1)
- sound localization (1)
- speech and language pathologist (1)
- speech perception (1)
- sphingosine (1)
- sphingosine 1-phosphate (1)
- sphingosine 1-phosphate homologues (1)
- sphingosine-1-phosphate (1)
- spinal metastasis (1)
- stairs (1)
- stakeholder analysis (1)
- statistics (1)
- stent patency (1)
- stereotactic frame (1)
- stereotactic neurosurgery (1)
- stomach neoplasms (1)
- store brands (1)
- study protocol (1)
- subchondral bone (1)
- subdural hematoma (1)
- sulfatides (1)
- sunitinib (1)
- surgical procedures (1)
- swarming (1)
- sympathetic (1)
- synovium (1)
- systematic review (1)
- taller-than-wide (1)
- targeted therapy (1)
- temporal lobe epilepsy (1)
- theory of mind (1)
- therapeutic anticoagulation (1)
- therapeutics (1)
- thrombin (1)
- thrombolysis (1)
- thrombosis (1)
- thrombospondins (1)
- thromboxane (1)
- tight junctions (1)
- tissue engineering (1)
- tooth loss (1)
- tooth transplantation (1)
- toric intraocular lens (1)
- total knee replacement (1)
- transcription factors (1)
- transcriptional cyclin-dependent kinase (1)
- transcriptomics (1)
- translatomics (1)
- trauma (1)
- treatment centres (1)
- triglycerides (1)
- trimeric autotransporters adhesin (1)
- tumor (1)
- tumor growth (1)
- ubiquitin (1)
- unmethylated MGMT (1)
- upgrading (1)
- upstaging (1)
- urethral stricture (1)
- urinary incontinence (1)
- urothelial carcinoma (1)
- v-ATPase (1)
- variant of concern (1)
- vascular integrity (1)
- viral replication (1)
- virologic failure (1)
- visual cortex (1)
- visual search (VS) (1)
- wastewater-based epidemiology (WBE) (1)
- weight reduction (1)
- whole genome pooled sequencing (1)
- workflow development (1)
- yellow fever mosquito (1)
Institute
- Medizin (365)
- Biochemie, Chemie und Pharmazie (10)
- Biowissenschaften (7)
- Frankfurt Institute for Advanced Studies (FIAS) (6)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (5)
- Ernst Strüngmann Institut (3)
- Georg-Speyer-Haus (3)
- Informatik und Mathematik (3)
- MPI für Biophysik (3)
- Psychologie und Sportwissenschaften (3)
In recent years, the number and type of treatment options in advanced bladder cancer (BC) have been rapidly evolving. To select an effective therapy and spare unnecessary side effects, predictive biomarkers are urgently needed. As the host’s anti-cancer immune response is by far the most effective system to impede malignant tumor growth, immune system-based biomarkers are promising. We have recently described altered proteasomal epitope processing as an effective immune escape mechanism to impair cytotoxic T-cell activity. By altering the neoantigens’ characteristics through different proteasomal peptide cleavage induced by non-synonymous somatic mutations, the ability for T-cell activation was decreased (“processing escapes”). In the present study, we analyzed primary chemo-naïve tissue samples of 26 adjuvant platinum-treated urothelial BC patients using a targeted next-generation sequencing panel followed by the epitope determination of affected genes, a machine-learning based prediction of epitope processing and proteasomal cleavage and of HLA-affinity as well as immune activation. Immune infiltration (immunohistochemistries for CD8, granzyme B, CD45/LCA) was digitally quantified by a pathologist and clinico-pathological and survival data were collected. We detected 145 epitopes with characteristics of a processing escape associated with a higher number of CD8-positive but lower number of granzyme B-positive cells and no association with PD-L1-expression. In addition, a high prevalence of processing escapes was associated with unfavorable overall survival. Our data indicate the presence of processing escapes in advanced BC, potentially creating a tumor-promoting pro-inflammatory environment with lowered anti-cancerous activity and independence from PD-L1-expression. The data also need to be prospectively validated in BC treated with immune therapy.
Background: To test the impact of urethral sphincter length (USL) and anatomic variants of prostatic apex (Lee-type classification) in preoperative multiparametric magnet resonance imaging (mpMRI) on mid-term continence in prostate cancer patients treated with radical prostatectomy (RP). Methods: We relied on an institutional tertiary-care database to identify patients who underwent RP between 03/2018 and 12/2019 with preoperative mpMRI and data available on mid-term (>6 months post-surgery) urinary continence, defined as usage 0/1 (-safety) pad/24 h. Univariable and multivariable logistic regression models were fitted to test for predictor status of USL and prostatic apex variants, defined in mpMRI measurements. Results: Of 68 eligible patients, rate of mid-term urinary continence was 81% (n = 55). Median coronal (15.1 vs. 12.5 mm) and sagittal (15.4 vs. 11.1 mm) USL were longer in patients reporting urinary continence in mid-term follow-up (both p < 0.01). No difference was recorded for prostatic apex variants distribution (Lee-type) between continent vs. incontinent patients (p = 0.4). In separate multivariable logistic regression models, coronal (odds ratio (OR): 1.35) and sagittal (OR: 1.67) USL, but not Lee-type, were independent predictors for mid-term continence. Conclusion: USL, but not apex anatomy, in preoperative mpMRI was associated with higher rates of urinary continence at mid-term follow-up.
The purpose of this study is to compare the efficacy and safety of microwave ablation (MWA) versus laser-induced thermotherapy (LITT) as a local treatment for hepatocellular carcinoma (HCC,) with regard to therapy response, survival rates, and complication rates as measurable outcomes. This retrospective study included 250 patients (52 females and 198 males; mean age: 66 ± 10 years) with 435 tumors that were treated by MWA and 53 patients (12 females and 41 males; mean age: 67.5 ± 8 years) with 75 tumors that were treated by LITT. Tumor response was evaluated using CEMRI (contrast-enhanced magnetic resonance imaging). Overall, 445 MWA sessions and 76 LITT sessions were performed. The rate of local tumor progression (LTP) and the rate of intrahepatic distant recurrence (IDR) were 6% (15/250) and 46% (115/250) in the MWA-group and 3.8% (2/53) and 64.2% (34/53) in the LITT-group, respectively. The 1-, 3-, and 5-year overall survival (OS) rates calculated from the date of diagnosis were 94.3%, 65.4%, and 49.1% in the MWA-group and 96.2%, 54.7%, and 30.2% in the LITT-group, respectively (p-value: 0.002). The 1-, 2-, and 3-year disease-free survival (DFS) rates were 45.9%, 30.6%, and 24.8% in the MWA-group and 54.7%, 30.2%, and 17% in the LITT-group, respectively (p-value: 0.719). Initial complete ablation rate was 97.7% (425/435) in the MWA-group and 98.7% (74/75) in the LITT-group (p-value > 0.99). The overall complication rate was 2.9% (13/445) in the MWA-group and 7.9% (6/76) in the LITT-group (p-value: 0.045). Based on the results, MWA and LITT thermal ablation techniques are well-tolerated, effective, and safe for the local treatment of HCC. However, MWA is recommended over LITT for the treatment of HCC, since the patients in the MWA-group had higher survival rates.
Brain metastases are a common finding upon initial diagnosis of otherwise locally limited non-small cell lung cancer. We present a retrospective case series describing three cases of patients with symptomatic, synchronous brain metastases and resectable lung tumors. The patients received local ablative treatment of the brain metastases followed by neoadjuvant immunochemotherapy with pemetrexed, cisplatin, and pembrolizumab. Afterwards, resection of the pulmonary lesion with curative intent was performed. One patient showed progressive disease 12 months after initial diagnosis, and passed away 31 months after initial diagnosis. Two of the patients are still alive and maintain a good quality of life with a progression-free survival and overall survival of 28 and 35 months, respectively, illustrating the potential of novel combinatorial treatment approaches.
Inguinal hernia repair (IHR) is a common procedure in childhood. Laparoscopic IHR has been evolving for the last three decades. Although clear advantages have been shown, adaptation in Germany has been slow. We aim to study the current status of pediatric laparoscopic IHR. A survey was sent to all 89 pediatric surgical departments in Germany on current practices and preferences of open versus laparoscopic IHR. Two nationwide databases of administrative claims data from 2019 were analyzed and correlated with responses from the survey. A total of 56% of the pediatric surgical departments supplied data through the quality reports. The recall of our survey was 58% of all pediatric surgery departments. According to the pooled data, laparoscopic IHR was performed in 8.2% of all inpatients treated. Laparoscopic IHR was considered a training procedure in 48% of the departments. Five different laparoscopic techniques were described (most commonly percutaneous closure of the hernia under laparoscopic vision). The choice between open and laparoscopic IHR was mainly determined by the child’s age. Currently, only a minority of German children undergo inguinal hernia repair by laparoscopy. More training opportunities in the form of hands-on and video workshops may lead to more widespread employment of the laparoscopic technique.
Reactive oxygen species (ROS) are important mediators of both physiological and pathophysiological signal transduction in the cardiovascular system. The effects of ROS on cellular processes depend on the concentration, localization, and duration of exposure. Cellular stress response mechanisms have evolved to mitigate the negative effects of acute oxidative stress. In this study, we investigate the short-term and long-term metabolic and transcriptomic response of human umbilical vein endothelial cells (HUVEC) to different types and concentrations of ROS. To generate intracellular H2O2, we utilized a lentiviral chemogenetic approach for overexpression of human D-amino acid oxidase (DAO). DAO converts D-amino acids into their corresponding imino acids and H2O2. HUVEC stably overexpressing DAO (DAO-HUVEC) were exposed to D-alanine (3 mM), exogenous H2O2 (10 µM or 300 µM), or menadione (5 µM) for various timepoints and subjected to global untargeted metabolomics (LC-MS/MS) and RNAseq by MACE (Massive analysis of cDNA ends). A total of 300 µM H2O2 led to pronounced changes on both the metabolic and transcriptomic level. In particular, metabolites linked to redox homeostasis, energy-generating pathways, and nucleotide metabolism were significantly altered. Furthermore, 300 µM H2O2 affected genes related to the p53 pathway and cell cycle. In comparison, the effects of menadione and DAO-derived H2O2 mainly occurred at gene expression level. Collectively, all types of ROS led to subtle changes in the expression of ribosomal genes. Our results show that different types and concentration of ROS lead to a different metabolic and transcriptomic response in endothelial cells.
Background and Aims: In patients with Rat sarcoma proto-oncogene (RAS) wild-type metastatic colorectal cancer (mCRC), anti-epidermal growth factor receptor (EGFR) antibodies have been established in first- and further therapy lines. Due to limited treatment options upon disease progression, anti-EGFR re-exposure is increasingly employed in real-world oncology. The aim of this study was to assess clinical implementation and utility of anti-EGFR retreatment strategies in real-world mCRC patients. Methods: In this monocentric retrospective study, we included 524 patients with CRC and identified patients who received an anti-EGFR-based treatment as well as anti-EGFR rechallenge (progression on first-line anti-EGFR therapy) or reintroduction (discontinuation due to intolerance/toxicity/other). Results: In total, 143 patients received an anti-EGFR-based first- or second-line treatment, showing a similar overall survival (OS) compared to the non-anti-EGFR treatment group (38.3 vs. 39.6 months, p = 0.88). Thirty-three patients met the inclusion criteria for anti-EGFR re-exposure and were either assigned to rechallenge (n = 21) or reintroduction (n = 12) subgroups. The median FU after re-exposure was 45.8 months. Cetuximab and Panitumumab were used in 21 and 12 patients, respectively, and the main chemotherapy at re-exposure was FOLFIRI in 39.4%. Anti-EGFR re-exposure was associated with a distinct trend towards a better outcome (median OS 56.0 vs. 35.4 months, p = 0.06). In a subgroup comparison, reintroduction was associated with a higher OS and PFS in trend compared to the rechallenge (mOS 66 vs. 52.4, n.s., mPFS 7.33 vs. 3.68 months, n.s.). Conclusions: This retrospective study provides real-world evidence underscoring that anti-EGFR re-exposure strategies might benefit patients independently of the reason for prior discontinuation.
Background: To test for differences in complication rates, in-hospital mortality, length of stay (LOS) and total hospital costs (THCs) in patients treated with neoadjuvant chemotherapy (NAC) prior to radical cystectomy (RC). Methods: Within the National (Nationwide) Inpatient Sample (NIS) database (2016–2019), we identified RC-treated, non-metastatic, lymph-node negative bladder cancer patients, stratified by NAC status. Trend analyses, multivariable logistic, multivariable Poisson and multivariable linear regression models were used. Results: We identified 4347 RC-treated bladder cancer patients. Of those, 805 (19%) received NAC prior to RC. Overall, complications rates did not differ (65 vs. 66%; p = 0.7). However, NAC patients harbored lower rates of surgical site (6 vs. 9%), cardiac (13 vs. 19%) and genitourinary (5.5 vs. 9.7%) complications. In-hospital mortality (<1.7 vs. 1.8%) and LOS (6 vs. 7 days) was lower in NAC patients (all p < 0.05). Moreover, NAC was an independent predictor of shorter LOS in multivariable Poisson regression models (Risk ratio: 0.86; p < 0.001) and an independent predictor for higher THCs in multivariable linear regression models (Odds ratio: 1474$; p = 0.02). Conclusion: NAC was not associated with higher complication rates and in-hospital mortality. Contrary, NAC was associated with shorter LOS, yet moderately higher THCs. The current analysis suggests no detriment from NAC in the context of RC.
Traumatic brain injury (TBI) is often complicated by long-lasting disabilities, including headache, fatigue, insomnia, hyperactivity, and cognitive deficits. In a previous study in mice, we showed that persistent non-goal-directed hyperactivity is a characteristic post-TBI behavior that was associated with low levels of endocannabinoids in the perilesional cortex. We now analyzed lipidome patterns in the brain and plasma in TBI versus sham mice in association with key behavioral parameters and endocannabinoids. Lipidome profiles in the plasma and subcortical ipsilateral and contralateral brain were astonishingly equal in sham and TBI mice, but the ipsilateral perilesional cortex revealed a strong increase in neutral lipids represented by 30 species of triacylglycerols (TGs) of different chain lengths and saturation. The accumulation of TG was localized predominantly to perilesional border cells as revealed by Oil Red O staining. In addition, hexosylceramides (HexCer) and phosphatidylethanolamines (PE and ether-linked PE-O) were reduced. They are precursors of gangliosides and endocannabinoids, respectively. High TG, low HexCer, and low PE/PE-O showed a linear association with non-goal-directed nighttime hyperactivity but not with the loss of avoidance memory. The analyses suggest that TG overload and HexCer and PE deficiencies contributed to behavioral dimensions of post-TBI psychopathology.